机构ID,机构名称,公告日期,截止日期,报告年度,合并类型,报表来源,货币资金（元）,以公允价值计量且其变动计入当期损益的金融资产,应收票据,应收账款,预付款项,其他应收款,应收关联公司款,应收利息,应收股利,存货,其中：消耗性生物资产,一年内到期的非流动资产,其他流动资产,流动资产合计,可供出售金融资产,持有至到期投资,长期应收款,长期股权投资,投资性房地产,固定资产,在建工程,工程物资,固定资产清理,生产性生物资产,油气资产,无形资产,开发支出,商誉,长期待摊费用,递延所得税资产,其他非流动资产,非流动资产合计,资产总计,短期借款,以公允价值计量且其变动计入当期损益的金融负债,应付票据,应付账款,预收款项,应付职工薪酬,应交税费,应付利息,应付股利,其他应付款,应付关联公司款,一年内到期的非流动负债,其他流动负债,流动负债合计,长期借款,应付债券,长期应付款,专项应付款,预计负债,递延所得税负债,其他非流动负债,非流动负债合计,负债合计,实收资本（或股本）,资本公积,盈余公积,专项储备,减：库存股,一般风险准备,未分配利润,归属于母公司所有者权益,少数股东权益,外币报表折算价差,非正常经营项目收益调整,所有者权益（或股东权益）合计,负债和所有者（或股东权益）合计,其他综合收益,递延收益-非流动负债,结算备付金,拆出资金,发放贷款及垫款-流动资产,衍生金融资产,应收保费,应收分保账款,应收分保合同准备金,买入返售金融资产,划分为持有待售的资产,发放贷款及垫款-非流动资产,向中央银行借款,吸收存款及同业存放,拆入资金,衍生金融负债,卖出回购金融资产款,应付手续费及佣金,应付分保账款,保险合同准备金,代理买卖证券款,代理承销证券款,划分为持有待售的负债,预计负债-流动负债,递延收益-流动负债,其中：优先股-非流动负债,永续债-非流动负债,长期应付职工薪酬,其他权益工具,其中：优先股-所有者权益,永续债-所有者权益
300601,康泰生物,2017-04-25,2017-03-31,2017-03-31,合并本期,定期报告,99206738.67,,1729011.2,356290132.46,20595335.41,11766183.11,,,,172393383.49,,,25000000.0,686980784.34,,,,,480609.91,256898074.42,503291428.14,,,,,134719846.93,61200992.8,,5408124.59,50745019.49,37247124.12,1049991220.4,1736972004.74,21000000,,5678976.3,42258933.19,47042385.65,6487357.53,11491938.71,519748.82,,259857704.07,,17541896,4296000,416174940.27,276978338.08,,25742300,,2200000.0,2122058.38,,446428295.05,862603235.32,411000000,266516420.57,,,,,196852348.85,874368769.42,,,,874368769.42,1736972004.74,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
300601,康泰生物,2017-07-18,2017-06-30,2017-06-30,合并本期,定期报告,86578503.59,,0.0,492353808.77,14108105.25,13059965.98,,,,175520993.61,,,2484001.74,784105378.94,,,,,480609.91,248147307.31,520898436.39,,,,,132177773.17,69047731.35,,4644178.47,59503947.98,42743531.67,1077643516.25,1861748895.19,20000000,,6934249.5,39133378.78,47256357.27,8829634.54,11470124.68,478598.95,,344151692.14,,27541896,4296000,510091931.86,295243992.84,,25742300,,2195650.52,2001238.54,,459410957.31,969502889.17,411000000,266637240.41,,,,,214608765.61,892246006.02,,,,892246006.02,1861748895.19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
